TY  - JOUR
T1  - Exploring the Role of CRP Analysis and Obesity in the Disparities of COVID-19 Outcomes
A1  - Leonidas Palaiodimos
A1  - Ryad Ali
A1  - Hugo O. Teo
A1  - Sahana Parthasarathy
A1  - Dimitrios Karamanis
A1  - Natalia Chamorro-Pareja
A1  - Damianos G. Kokkinidis
A1  - Sharanjit Kaur
A1  - Michail Kladas
A1  - Jeremy Sperling
A1  - Michael Chang
A1  - Kenneth Hupart
A1  - Colin Cha-Fong
A1  - Shankar Srinivasan
A1  - Preeti Kishore
A1  - Nichola Davis
A1  - Robert T. Faillace
JF  - Journal of Medical Sciences and Interdisciplinary Research
JO  - J Med Sci Interdiscip Res
SN  - 3108-4826
Y1  - 2022
VL  - 2
IS  - 1
DO  - 10.51847/GnA3T0sCP1
SP  - 1
EP  - 8
N2  - Obesity has now become a global concern and contributes to various risk factors, especially in Western countries, where its prevalence has increased sharply. This surge has led to a significant increase in cardiovascular diseases in the general population. Inflammatory proteins, such as C-reactive protein (CRP), play an important role in the acute phase response to inflammation. This study aimed to investigate the impact of obesity on inflammation, as measured by CRP levels, in obese patients who exhibit frequent inflammatory responses. These patients may be at an elevated risk of contracting COVID-19 due to the effects of obesity on the immune system, with variations observed based on gender, ethnicity, and age. Our findings emphasize the importance of obese individuals maintaining low CRP levels to mitigate the risk of COVID-19 infection.
UR  - https://smerpub.com/article/exploring-the-role-of-crp-analysis-and-obesity-in-the-disparities-of-covid-19-outcomes-z8fa6vy21qigm89
ER  -